Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1628, 2008-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Infliximab and adalimumab come out on top for psoriasis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 548, 2008-01 ,pp. :
Access to resources
Recommend
Adalimumab/infliximab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 25 case reports
Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. :
Adalimumab/infliximab: Psoriasis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1209, 2008-01 ,pp. :